Showing results (451-460 of 6,392) with videos related to

Sort By:
Pageof 640
European Journal of Nuclear Medicine and Molecular Imaging|November 10, 2018
Minimal rest activity for SPECT myocardial perfusion imaging in a one-day stress-first protocolJ D van Dijk, J A van Dalen, S Knollema, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 24, 2018
Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurementsMahsa Eskian, Abass Alavi, MirHojjat Khorasanizadeh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2018
Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infectionsAlfred O Ankrah, Lambert F R Span, Hans C Klein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2018
Prognostic analysis of interim 18F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapyLing Yuan, Michael C Kreissl, Liping Su, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2016
Radiosynoviorthesis in hemophilic arthropathy: pathologic blood pool imaging on pre-therapeutic bone scintigraphy is not a predictor of treatment successAmir Sabet, Andreas Christian Strauss, Jan Schmolders, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2016
Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [68Ga]PSMA I&T and comparison with published data of [68Ga]PSMA HBED-CCChristoph Berliner, Milena Tienken, Thorsten Frenzel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2016
Nuclear medicine imaging of multiple myeloma, particularly in the relapsed settingEsther G M de Waal, Andor W J M Glaudemans, Carolien P Schröder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2016
Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenibYoojoo Lim, Ji-In Bang, Sae-Won Han, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 29, 2016
High clinical and morphologic response using 90Y-DOTA-octreotate sequenced with 177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumoursGrace Kong, Jason Callahan, Michael S Hofman, et al.
Pageof 640